SYK Stryker Corporation
USHealthcareAs of 2026-07-08 11:42
Why SYK matters now
Stryker Corporation (SYK) is a US stock in Healthcare. The latest InvestLog snapshot shows $328.72 with -0.31% on the session and $126.02B in market capitalization; recent performance reads 1-month -3.13% and YTD -12.43%.
The latest financial table shown here is Q1 2026, with revenue of $6.02B, net income of $745.0M, and EPS of $1.93. Investors can compare that operating picture with valuation signals such as P/E 39.15 and FCF yield 3.9%.
The latest indexable market news headline is "Stryker: Medtech On Sale, Benefiting From Industry Growth" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Buy with a median target of $394.00; recent insider activity includes Stiles Spencer S filing G-Gift; recent congressional disclosure data includes Ro Khanna Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
39.15
PEG
4.63
P/B
5.13
P/S
4.67
EV/EBITDA
21.15
DCF Value
$334.96
FCF Yield
3.9%
Div Yield
1.1%
Margins & Returns
Gross Margin
63.7%
Operating Margin
21.3%
Net Margin
13.2%
ROE
15.1%
ROA
7.2%
ROIC
9.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $6.02B | $745.0M | $1.93 |
| Q4 2025 | $7.17B | $849.0M | $2.20 |
| FY 2025 | $25.12B | $3.25B | $8.40 |
| Q3 2025 | $6.06B | $859.0M | $2.22 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$387.46
Target (Median)
$394.00
Target Range
$315.00 - $465.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.79
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.